2008
DOI: 10.1016/j.jaad.2007.10.489
|View full text |Cite
|
Sign up to set email alerts
|

Transforming growth factor–β overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 20 publications
0
12
1
Order By: Relevance
“…Rarely, cutaneous lesions harboring hematopoietic elements may show dermal sclerosis. The demonstration of transforming growth factor beta in the immature hematopoietic cells may explain the fibrogenic activity (14). However, there was no evidence of fibrosis in the present case.…”
Section: Discussioncontrasting
confidence: 48%
“…Rarely, cutaneous lesions harboring hematopoietic elements may show dermal sclerosis. The demonstration of transforming growth factor beta in the immature hematopoietic cells may explain the fibrogenic activity (14). However, there was no evidence of fibrosis in the present case.…”
Section: Discussioncontrasting
confidence: 48%
“…Literature documentation of CEMH comprises a total of about 30 cases and appears to be most frequently associated with myelofi brosis or myeloproliferative disorders (Patel et al 1995 ;Revenga et al 2000 ;Fernandez Acenero et al 2003 ). Increased levels of transforming growth factor-beta appear to be associated with CEMH in patients with idiopathic myelofi brosis ( Collie et al 2013 ;Corella et al 2008 ;Haniffa et al 2006 ;Kawakami et al 2008 ;Kwon et al 1999 ;Lane et al 2002 ;Miyata et al 2008 ;Mizoguchi et al 1990 ;Pagerols et al 1998 ;Rodriguez et al 1991 ;Rogalski et al 2002 ;Ruberto et al 1995 ).…”
Section: Pyoderma Gangrenosum Associated With G-csfmentioning
confidence: 99%
“… 1 , 2 , 3 However, the mechanism underlying the specific migration of myeloblasts to the skin remains uncertain. In 2008, Kawakami et al 4 presumed that transforming growth factor–beta 1 (TGF-β1) released by hematopoietic cells within the cutaneous extramedullary hematopoiesis could play a role in the onset of such skin lesions. 4 …”
Section: Introductionmentioning
confidence: 99%